#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4201411	F	Growth inhibition of Plasmodium falciparum 3D7 asynchronous cultures by PicoGreen dye based assay	Plasmodium falciparum	18		organism-based format	Scientific Literature
2.	ALA4201412	A	Effect on DXR protein level in Plasmodium falciparum 3D7 at 5 times growth inhibitory IC50 incubated for 10 hrs by LC-MS/MS method	Plasmodium falciparum	1		organism-based format	Scientific Literature
3.	ALA4201413	A	Cytotoxicity in human HepG2 cells	Homo sapiens	2		cell-based format	Scientific Literature
4.	ALA4201414	T	Selectivity index, ratio of IC50 for cytotoxicity in human HepG2 cells to IC50 for growth inhibition of Plasmodium falciparum 3D7 asynchronous cultures		2		cell-based format	Scientific Literature
5.	ALA4201415	A	Half life in mouse liver microsomes	Mus musculus	2		microsome format	Scientific Literature
6.	ALA4201416	A	Half life in mouse plasma	Mus musculus	2		cell-free format	Scientific Literature
7.	ALA4201417	F	Growth inhibition of Plasmodium falciparum 3D7 asynchronous cultures at 0.01 to 100 uM incubated for 72 hrs in presence of excess IPP by PicoGreen dye based assay	Plasmodium falciparum	2		organism-based format	Scientific Literature
8.	ALA4201418	B	Inhibition of DXR in Plasmodium falciparum 3D7 assessed as reduction in MEP levels at 5 times growth inhibitory IC50 incubated for 10 hrs by LC-MS/MS method	Plasmodium falciparum 3D7	1		single protein format	Scientific Literature
9.	ALA4201419	B	Inhibition of DXR in Plasmodium falciparum 3D7 assessed as reduction in CDP-ME levels at 5 times growth inhibitory IC50 incubated for 10 hrs by LC-MS/MS method	Plasmodium falciparum 3D7	1		single protein format	Scientific Literature
10.	ALA4201420	B	Inhibition of DXR in Plasmodium falciparum 3D7 assessed as reduction in MEcPP levels at 5 times growth inhibitory IC50 incubated for 10 hrs by LC-MS/MS method	Plasmodium falciparum 3D7	1		single protein format	Scientific Literature
11.	ALA4201421	F	Resistance index, ratio of IC50 for Plasmodium falciparum containing had1 mutation to IC50 for growth inhibition of wild type Plasmodium falciparum 3D7 asynchronous cultures	Plasmodium falciparum	2		organism-based format	Scientific Literature
12.	ALA4201422	F	Growth inhibition of Plasmodium falciparum containing had1 mutation expressing GFP-HAD1 by PicoGreen dye based assay	Plasmodium falciparum	2		organism-based format	Scientific Literature
13.	ALA4201425	F	Antimalarial activity against luciferase-expressing Plasmodium berghei ANKA infected in Swiss Webster mouse assessed as reduction in parasitemia by measuring reduction in luciferin signal intensity at 20 mg/kg, ip administered daily for 5 days starting from 2 days post infection by luciferase-luciferin based reporter assay relative to untreated control	Plasmodium berghei	1		organism-based format	Scientific Literature
14.	ALA4201426	F	Antimalarial activity against luciferase-expressing Plasmodium berghei ANKA infected in Swiss Webster mouse assessed as reduction in parasitemia by measuring reduction in luciferin signal intensity at 50 mg/kg, ip administered daily for 5 days starting from 2 days post infection by luciferase-luciferin based reporter assay relative to untreated control	Plasmodium berghei	1		organism-based format	Scientific Literature
15.	ALA4201427	T	Toxicity in luciferase-expressing Plasmodium berghei ANKA infected Swiss Webster mouse assessed as induction of adverse events at 20 mg/kg, ip administered daily for 5 days starting from 2 days post infection	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA4201428	T	Toxicity in luciferase-expressing Plasmodium berghei ANKA infected Swiss Webster mouse assessed as induction of adverse events at 50 mg/kg, ip administered daily for 5 days starting from 2 days post infection	Mus musculus	1		organism-based format	Scientific Literature
17.	ALA4201429	A	Drug metabolism in Swiss Webster mouse assessed as plasma concentration of sodium hydrogen [(1E)-3-(N-hydroxyformamido)prop-1-en-1-yl]phosphonate at 20 mg/kg, ip measured over 8 hrs post dose by LC-MS/MS method	Mus musculus	1		organism-based format	Scientific Literature
18.	ALA4201430	A	Ratio of drug metabolism in Swiss Webster mouse assessed as plasma concentration of sodium hydrogen [(1E)-3-(N-hydroxyformamido)prop-1-en-1-yl]phosphonate at 20 mg/kg, ip measured over 8 hrs post dose by LC-MS/MS method to IC50 for growth inhibition of Plasmodium falciparum 3D7 asynchronous cultures		1		organism-based format	Scientific Literature